SYK.F
Stryker Corporation
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
280.70
▼ 8.80 (3.04%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
280.10
Prev close
289.50
Day high
280.70
Day low
280.10
Volume
54
Market cap
$107.67B
P/E (TTM)
34.02
52W range
238.90 – 340.50
Day trading desk
Gap from prior close
-3.25%
Prior close 289.50
VWAP
280.70
0.00% from price
Relative volume
0.36×
Quiet session
Session range
0.21%
280.10 – 280.70
Position in range
100%
Near session high
ATR (14D)
5.41
1.93% of price
Prior day high
291.00
PDH
Prior day low
288.80
PDL
Bid / ask spread
—
Quote not published
Session volume
54
Avg 150
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.49%
-3.1%
1M
+1.26%
-2.5%
3M
+3.31%
+0.2%
6M
-13.76%
-24.8%
YTD
-6.28%
-18.6%
1Y
-15.17%
-35.2%
3Y
+7.75%
-66.4%
5Y
+20.01%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SYK.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
20.57M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 18, 26 | KING DEBRA Officer |
SELL | 826 | $277.79K | Direct |
| Jun 1, 26 | STILES SPENCER S President |
STOCK | 1.61K | $0 | Direct |
| May 28, 26 | FLETCHER ROBERT S Officer |
SELL | 4.54K | $1.39M | Direct |
| May 26, 26 | STRYKER RONDA E Director |
SELL | 310.00K | $96.79M | Indirect |
| May 11, 26 | FINK MARY KATHRYN Officer |
SELL | 8.72K | $2.47M | |
| May 8, 26 | FINK MARY KATHRYN Officer |
CONVERSION | 21.58K | $3.63M | Direct |
| May 6, 26 | MONTAGNINO KIMBERLY ANN Officer |
STOCK | 677 | $0 | Direct |
| May 6, 26 | MACEDA EMMANUEL PEREZ Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | KING DEBRA Chief Technology Officer |
STOCK | 1.02K | $0 | Direct |
| May 6, 26 | SURI RAJEEV Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | SKEETE TATUM LISA M Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | CAFORIO GIOVANNI Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | RUGGERI RACHEL Director |
STOCK | 762 | $0 | Direct |
| May 6, 26 | STRYKER RONDA E Director |
STOCK | 762 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BECKER YIN C |
Officer | 36.05K | Conversion of Exercise of derivative security |
BOEHNLEIN GLENN S |
Chief Financial Officer | 13.20K | Conversion of Exercise of derivative security |
FINK MARY KATHRYN |
Officer | — | Sale |
GOLSTON ALLAN C |
Director | 14.89K | Conversion of Exercise of derivative security |
LOBO KEVIN A |
Chief Executive Officer | 222.95K | Conversion of Exercise of derivative security |
MENON VIJU S |
Officer | 17.58K | Conversion of Exercise of derivative security |
PIERCE JAMES ANDREW |
Officer | 83.89K | Conversion of Exercise of derivative security |
SILVERNAIL ANDREW K. |
Director | 18.46K | Stock Award(Grant) |
STILES SPENCER S |
President | 77.72K | Stock Gift |
STRYKER RONDA E |
Director | — | Sale |
Fundamentals
Market cap$107.67B
Enterprise value$119.64B
Revenue (TTM)$25.84B
Gross profit$16.95B
EBITDA$7.38B
Net income$3.73B
EPS (TTM)$8.25
Free cash flow$4.11B
Total cash$3.48B
Total debt$15.45B
Book value / share$54.22
Shares outstanding383.57M
Float348.14M
Short % of float—
Dividend yield1.09%
Beta (5Y)0.77
Valuation & profitability ratios
Trailing P/E34.02
Forward P/E26.81
PEG ratio1.55
Price / sales—
Price / book5.18
EV / revenue4.63
EV / EBITDA16.22
Gross margin65.59%
Operating margin27.02%
Profit margin14.43%
Return on equity16.51%
Return on assets8.16%
Debt / equity64.39
Current ratio2.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $25.12B | $22.59B | $20.50B | $18.45B | +11.2% |
| Operating revenue | $25.12B | $22.59B | $20.50B | $18.45B | +11.2% |
| Cost of revenue | $9.05B | $8.15B | $7.44B | $6.87B | +11.0% |
| Gross profit | $16.07B | $14.44B | $13.06B | $11.58B | +11.3% |
| Research & development | $1.62B | $1.47B | $1.39B | $1.45B | +10.7% |
| Selling, general & admin | $8.65B | $7.68B | $7.11B | $6.39B | +12.6% |
| Total operating expense | $11.01B | $9.77B | $9.13B | $8.47B | +12.6% |
| Operating income | $5.06B | $4.67B | $3.92B | $3.11B | +8.4% |
| Net interest income | -$607.00M | -$409.00M | -$363.00M | — | -48.4% |
| Pre-tax income | $4.51B | $3.49B | $3.67B | $2.68B | +29.3% |
| Tax provision | $1.27B | $499.00M | $508.00M | $325.00M | +154.1% |
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | +8.5% |
| Net income to common | $3.25B | $2.99B | $3.17B | $2.36B | +8.5% |
| Basic EPS | 8.49 | 7.86 | 8.34 | 6.23 | +8.0% |
| Diluted EPS | 8.40 | 7.76 | 8.25 | 6.17 | +8.2% |
| EBIT | $5.12B | $3.90B | $4.04B | $3.11B | +31.3% |
| EBITDA | $6.31B | $4.95B | $5.06B | $4.11B | +27.5% |
| Basic shares | 382.20M | 381.00M | 379.60M | 378.20M | +0.3% |
| Diluted shares | 386.50M | 385.60M | 383.70M | 382.20M | +0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $4.01B | $3.65B | $2.97B | $1.84B | +9.8% |
| Cash & short-term investments | $4.10B | $4.49B | $3.05B | $1.93B | -8.7% |
| Accounts receivable | $4.04B | $3.99B | $3.77B | $3.56B | +1.3% |
| Inventory | $5.31B | $4.77B | $4.84B | $4.00B | +11.2% |
| Total current assets | $14.76B | $14.85B | $12.52B | $10.28B | -0.6% |
| Property, plant & equipment | $3.88B | $3.45B | $3.21B | $2.97B | +12.4% |
| Goodwill & intangibles | $24.97B | $20.25B | $19.84B | $19.77B | +23.3% |
| Total assets | $47.84B | $42.97B | $39.91B | $36.88B | +11.3% |
| Total current liabilities | $7.79B | $7.62B | $7.92B | $6.30B | +2.3% |
| Current debt | $1.00B | $1.41B | $2.09B | $1.19B | -29.0% |
| Long-term debt | $14.86B | $12.19B | $10.90B | $11.86B | +21.9% |
| Total debt | $15.86B | $13.60B | $12.99B | $13.05B | +16.6% |
| Total liabilities | $25.42B | $22.34B | $21.32B | $20.27B | +13.8% |
| Retained earnings | $20.47B | $18.53B | $16.77B | $14.77B | +10.5% |
| Shareholder equity | $22.42B | $20.63B | $18.59B | $16.62B | +8.7% |
| Working capital | $6.96B | $7.23B | $4.60B | $3.97B | -3.7% |
| Net tangible assets | -$2.55B | $384.00M | -$1.24B | -$3.15B | -764.6% |
| Shares issued | 382.50M | 381.40M | 380.10M | 378.70M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | — | +8.5% |
| Depreciation & amortisation | $1.19B | $1.05B | $1.03B | $998.00M | — | +13.6% |
| Stock-based compensation | $243.00M | $229.00M | $205.00M | $168.00M | — | +6.1% |
| Change in working capital | -$373.00M | -$683.00M | -$517.00M | -$1.24B | — | +45.4% |
| Operating cash flow | $5.04B | $4.24B | $3.71B | $2.62B | — | +18.9% |
| Capital expenditure | -$761.00M | -$755.00M | -$575.00M | -$588.00M | — | -0.8% |
| Investing cash flow | -$4.87B | -$3.00B | -$962.00M | -$2.92B | — | -62.2% |
| Share buybacks | — | — | — | — | $0 | — |
| Dividends paid | -$1.28B | -$1.22B | -$1.14B | -$1.05B | — | -5.3% |
| Financing cash flow | $113.00M | -$525.00M | -$1.59B | -$749.00M | — | +121.5% |
| Free cash flow | $4.28B | $3.49B | $3.14B | $2.04B | — | +22.8% |
| End cash position | $4.01B | $3.65B | $2.97B | $1.84B | — | +9.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $6.59B | $6.02B | $7.17B | $6.06B | $6.02B | — | +9.5% |
| Operating revenue | $6.59B | $6.02B | $7.17B | $6.06B | $6.02B | — | +9.5% |
| Cost of revenue | $2.09B | $2.21B | $2.54B | $2.21B | $2.18B | — | -5.4% |
| Gross profit | $4.50B | $3.81B | $4.63B | $3.85B | $3.84B | — | +18.1% |
| Research & development | $434.00M | $413.00M | $401.00M | $410.00M | $407.00M | — | +5.1% |
| Selling, general & admin | $2.23B | $2.28B | $2.23B | $2.04B | $2.08B | — | -2.3% |
| Total operating expense | $2.84B | $2.87B | $2.82B | $2.64B | $2.67B | — | -1.3% |
| Operating income | $1.66B | $936.00M | $1.81B | $1.21B | $1.17B | — | +77.4% |
| Net interest income | -$141.00M | -$148.00M | — | — | -$159.00M | -$137.00M | +4.7% |
| Pre-tax income | $1.56B | $850.00M | $1.71B | $1.03B | $1.02B | — | +84.0% |
| Tax provision | $288.00M | $105.00M | $856.00M | $170.00M | $132.00M | — | +174.3% |
| Net income | $1.28B | $745.00M | $849.00M | $859.00M | $884.00M | — | +71.3% |
| Net income to common | $1.28B | $745.00M | $849.00M | $859.00M | $884.00M | — | +71.3% |
| Basic EPS | 3.32 | 1.95 | 2.21 | — | 2.32 | 1.71 | +70.3% |
| Diluted EPS | 3.30 | 1.93 | 2.20 | — | 2.29 | 1.69 | +71.0% |
| EBIT | $1.71B | $998.00M | $1.87B | $1.21B | $1.18B | — | +70.8% |
| EBITDA | $2.00B | $1.30B | $2.19B | $1.52B | $1.47B | — | +54.2% |
| Basic shares | 383.50M | 382.90M | 382.50M | — | 382.20M | 381.70M | +0.2% |
| Diluted shares | 386.00M | 386.50M | 386.50M | — | 386.40M | 386.40M | -0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.39B | $2.88B | $4.01B | $3.26B | $2.38B | +17.8% |
| Cash & short-term investments | $3.48B | $2.96B | $4.10B | $3.34B | $2.46B | +17.2% |
| Accounts receivable | $3.74B | $3.57B | $4.04B | $3.64B | $3.92B | +4.8% |
| Inventory | $5.52B | $5.42B | $5.31B | $5.37B | $5.29B | +1.9% |
| Total current assets | $14.42B | $13.34B | $14.76B | $13.71B | $13.00B | +8.1% |
| Property, plant & equipment | $3.96B | $3.89B | $3.88B | $3.73B | $3.70B | +1.8% |
| Goodwill & intangibles | $25.33B | $24.70B | $24.97B | $25.10B | $25.14B | +2.5% |
| Total assets | $47.93B | $46.29B | $47.84B | $47.06B | $46.33B | +3.5% |
| Total current liabilities | $6.68B | $6.32B | $7.79B | $7.41B | $7.29B | +5.8% |
| Current debt | $750.00M | $499.00M | $1.00B | $1.75B | $1.75B | +50.3% |
| Long-term debt | $14.19B | $14.22B | $14.86B | $14.85B | $14.83B | -0.2% |
| Total debt | $14.94B | $14.72B | $15.86B | $16.59B | $16.58B | +1.5% |
| Total liabilities | $23.94B | $23.31B | $25.42B | $25.27B | $25.14B | +2.7% |
| Retained earnings | $21.82B | $20.88B | $20.47B | $19.96B | $19.42B | +4.5% |
| Shareholder equity | $23.99B | $22.98B | $22.42B | $21.79B | $21.19B | +4.4% |
| Working capital | $7.73B | $7.02B | $6.96B | $6.30B | $5.71B | +10.1% |
| Net tangible assets | -$1.34B | -$1.73B | -$2.55B | -$3.32B | -$3.95B | +22.4% |
| Shares issued | 383.57M | 383.36M | 382.50M | 382.42M | 382.31M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $1.28B | $745.00M | $849.00M | $859.00M | $884.00M | +71.3% |
| Depreciation & amortisation | $296.00M | $300.00M | $316.00M | $309.00M | $296.00M | -1.3% |
| Stock-based compensation | $54.00M | $87.00M | $48.00M | $62.00M | $49.00M | -37.9% |
| Change in working capital | -$431.00M | -$560.00M | $709.00M | $161.00M | -$351.00M | +23.0% |
| Operating cash flow | $1.26B | $581.00M | $2.14B | $1.54B | $1.11B | +117.0% |
| Capital expenditure | -$202.00M | -$166.00M | -$268.00M | -$187.00M | -$183.00M | -21.7% |
| Investing cash flow | -$639.00M | -$185.00M | -$305.00M | -$321.00M | -$104.00M | -245.4% |
| Dividends paid | -$337.00M | -$337.00M | -$321.00M | -$322.00M | -$321.00M | 0.0% |
| Financing cash flow | -$95.00M | -$1.51B | -$1.09B | -$339.00M | -$989.00M | +93.7% |
| Free cash flow | $1.06B | $415.00M | $1.88B | $1.35B | $928.00M | +155.2% |
| End cash position | $3.39B | $2.88B | $4.01B | $3.26B | $2.38B | +17.8% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $6.69B | +10.4% |
| Next quarter | — | — | $8.00B | +11.6% |
| Current year | — | — | $27.30B | +8.7% |
| Next year | — | — | $29.67B | +8.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders5.36%
Held by institutions82.76%
Institutions holding3.04K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
292.10
-3.90% from price
SMA 20
292.82
-4.14% from price
SMA 50
284.59
-1.37% from price
SMA 100
277.45
+1.17% from price
SMA 200
292.61
-4.07% from price
EMA 12
289.70
-3.11% from price
EMA 26
288.85
-2.82% from price
EMA 50
285.56
-1.70% from price
RSI (14)
43.3
Neutral
MACD (12,26,9)
0.84
Hist -1.80
ATR (14)
5.41
1.93% of price
Realised vol 30D
42.2%
Annualised
Bollinger upper
305.32
20, 2σ
Bollinger lower
280.32
20, 2σ
50 / 200 cross
Death
284.59 vs 292.61
Trend bias
Below 200
-4.07%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.13
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
42.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-29.3%
Peak to trough
Max drawdown 5Y
-37.6%
Peak to trough
ATR 14
5.41
1.93% of price
Beta (reported)
0.77
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 26 | Wolfe Research | DOWNGRADE | Outperform | Peer Perform |
| Aug 3, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jul 31, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 31, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jul 31, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 9, 26 | BMO Capital | INITIATED | Market Perform | Outperform |
| Jul 6, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jun 5, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
| May 4, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| May 4, 26 | Barclays | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$3.05 / yr
Forward yield1.09%
5-year avg yield0.99%
Payout ratio36.06%
Ex-dividend dateSep 30, 2026
Next pay date—
Last split—
Split date—
Headlines
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 13m ago
Dow Jones Futures Fall With Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 15m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 19m ago
FIA Hails Success of Landmark INDYCAR Freedom 250 Grand Prix as Motorsport Takes Centre Stage in Washington D.C.
Business Wire · 23m ago
The next big oil trade may have nothing to do with oil stocks
TheStreet · 23m ago
First lady Melania Trump says she 'loved' racing as a child
USA TODAY · 23m ago
Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?
Insider Monkey · 24m ago
Crowder College offering training courses in August, September
The Joplin Globe, Mo. · 25m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.